{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:57:43Z","timestamp":1789747063774,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T00:00:00Z","timestamp":1383004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T00:00:00Z","timestamp":1383004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1038\/leu.2013.316","type":"journal-article","created":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T07:33:26Z","timestamp":1383032006000},"page":"1081-1091","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Enhancers of Polycomb EPC1 and EPC2 sustain the oncogenic potential of MLL leukemia stem cells"],"prefix":"10.1038","volume":"28","author":[{"given":"X","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G J","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J T","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T D D","family":"Somerville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T C P","family":"Somervaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,29]]},"reference":[{"key":"BFleu2013316_CR1","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"The Cancer Genome Atlas Research Network","year":"2013","unstructured":"The Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013; 368: 2059\u20132074.","journal-title":"N Engl J Med"},{"key":"BFleu2013316_CR2","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/leu.2013.78","volume":"27","author":"J de Boer","year":"2013","unstructured":"de Boer J, Walf-Vorderwulbecke V, Williams O . In focus: MLL-rearranged leukemia. Leukemia 2013; 27: 1224\u20131228.","journal-title":"Leukemia"},{"key":"BFleu2013316_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ccr.2009.11.020","volume":"17","author":"ME Figueroa","year":"2010","unstructured":"Figueroa ME, Lugthart S, Li Y, Erpelinck-Verschueren C, Deng X, Christos PJ et al. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell 2010; 17: 13\u201327.","journal-title":"Cancer Cell"},{"key":"BFleu2013316_CR4","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1182\/blood-2009-01-200519","volume":"114","author":"ME Figueroa","year":"2009","unstructured":"Figueroa ME, Skrabanek L, Li Y, Jiemjit A, Fandy TE, Paietta E et al. MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood 2009; 114: 3448\u20133458.","journal-title":"Blood"},{"key":"BFleu2013316_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/leu.2013.242","volume":"28","author":"T Schoofs","year":"2014","unstructured":"Schoofs T, Berdel WE, Muller-Tidow C . Origins of aberrant DNA methylation in acute myeloid leukemia. Leukemia 2014; 28: 1\u201314.","journal-title":"Leukemia"},{"key":"BFleu2013316_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1470-2045(09)70003-8","volume":"10","author":"P Fenaux","year":"2009","unstructured":"Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol 2009; 10: 223\u2013232.","journal-title":"Lancet Oncol"},{"key":"BFleu2013316_CR7","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/leu.2013.173","volume":"27","author":"EH Estey","year":"2013","unstructured":"Estey EH . Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia. Leukemia 2013; 27: 1803\u20131812.","journal-title":"Leukemia"},{"key":"BFleu2013316_CR8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1200\/JCO.2009.22.9088","volume":"28","author":"AK Burnett","year":"2010","unstructured":"Burnett AK, Hills RK, Milligan DW, Goldstone AH, Prentice AG, McMullin MF et al. Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial. J Clin Oncol 2010; 28: 586\u2013595.","journal-title":"J Clin Oncol"},{"key":"BFleu2013316_CR9","doi-asserted-by":"crossref","unstructured":"Wiseman DH, Greystoke BF, Somervaille TC . The variety of leukemic stem cells in myeloid malignancy. Oncogene 2013; e-pub ahead of print 8 July 2013 doi:10.1038\/onc.2013.269.","DOI":"10.1038\/onc.2013.269"},{"key":"BFleu2013316_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ccr.2011.06.009","volume":"20","author":"SR Daigle","year":"2011","unstructured":"Daigle SR, Olhava EJ, Therkelsen CA, Majer CR, Sneeringer CJ, Song J et al. Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. Cancer Cell 2011; 20: 53\u201365.","journal-title":"Cancer Cell"},{"key":"BFleu2013316_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ccr.2012.03.014","volume":"21","author":"WJ Harris","year":"2012","unstructured":"Harris WJ, Huang X, Lynch JT, Spencer GJ, Hitchin JR, Li Y et al. The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells. Cancer Cell 2012; 21: 473\u2013487.","journal-title":"Cancer Cell"},{"key":"BFleu2013316_CR12","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature10334","volume":"478","author":"J Zuber","year":"2011","unstructured":"Zuber J, Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 2011; 478: 524\u2013528.","journal-title":"Nature"},{"key":"BFleu2013316_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature10509","volume":"478","author":"MA Dawson","year":"2011","unstructured":"Dawson MA, Prinjha RK, Dittmann A, Giotopoulos G, Bantscheff M, Chan WI et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 2011; 478: 529\u2013533.","journal-title":"Nature"},{"key":"BFleu2013316_CR14","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/leu.2011.90","volume":"25","author":"BV Balgobind","year":"2011","unstructured":"Balgobind BV, Zwaan CM, Pieters R, Van den Heuvel-Eibrink MM . The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia. Leukemia 2011; 25: 1239\u20131248.","journal-title":"Leukemia"},{"key":"BFleu2013316_CR15","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1038\/leu.2013.135","volume":"27","author":"C Meyer","year":"2013","unstructured":"Meyer C, Hofmann J, Burmeister T, Groger D, Park TS, Emerenciano M et al. The MLL recombinome of acute leukemias in 2013. Leukemia 2013; 27: 2165\u20132176.","journal-title":"Leukemia"},{"key":"BFleu2013316_CR16","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/onc.2012.110","volume":"32","author":"J Shi","year":"2013","unstructured":"Shi J, Wang E, Zuber J, Rappaport A, Taylor M, Johns C et al. The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia. Oncogene 2013; 32: 930\u2013938.","journal-title":"Oncogene"},{"key":"BFleu2013316_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ccr.2006.08.020","volume":"10","author":"TC Somervaille","year":"2006","unstructured":"Somervaille TC, Cleary ML . Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 2006; 10: 257\u2013268.","journal-title":"Cancer Cell"},{"key":"BFleu2013316_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.stem.2008.11.015","volume":"4","author":"TC Somervaille","year":"2009","unstructured":"Somervaille TC, Matheny CJ, Spencer GJ, Iwasaki M, Rinn JL, Witten DM et al. Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell 2009; 4: 129\u2013140.","journal-title":"Cell Stem Cell"},{"key":"BFleu2013316_CR19","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545\u201315550.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2013316_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cell.2005.09.025","volume":"123","author":"A Yokoyama","year":"2005","unstructured":"Yokoyama A, Somervaille TC, Smith KS, Rozenblatt-Rosen O, Meyerson M, Cleary ML . The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 2005; 123: 207\u2013218.","journal-title":"Cell"},{"key":"BFleu2013316_CR21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/genetics\/105.2.357","volume":"105","author":"T Sato","year":"1983","unstructured":"Sato T, Russell MA, Denell RE . Homoeosis in Drosophila: a new enhancer of polycomb and related homoeotic mutations. Genetics 1983; 105: 357\u2013370.","journal-title":"Genetics"},{"key":"BFleu2013316_CR22","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1242\/dev.125.20.4055","volume":"125","author":"K Stankunas","year":"1998","unstructured":"Stankunas K, Berger J, Ruse C, Sinclair DA, Randazzo F, Brock HW . The enhancer of polycomb gene of Drosophila encodes a chromatin protein conserved in yeast and mammals. Development 1998; 125: 4055\u20134066.","journal-title":"Development"},{"key":"BFleu2013316_CR23","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1101\/gad.1056603","volume":"17","author":"AA Boudreault","year":"2003","unstructured":"Boudreault AA, Cronier D, Selleck W, Lacoste N, Utley RT, Allard S et al. Yeast enhancer of polycomb defines global Esa1-dependent acetylation of chromatin. Genes Dev 2003; 17: 1415\u20131428.","journal-title":"Genes Dev"},{"key":"BFleu2013316_CR24","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1128\/MCB.24.5.1884-1896.2004","volume":"24","author":"Y Doyon","year":"2004","unstructured":"Doyon Y, Selleck W, Lane WS, Tan S, Cote J . Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans. Mol Cell Biol 2004; 24: 1884\u20131896.","journal-title":"Mol Cell Biol"},{"key":"BFleu2013316_CR25","doi-asserted-by":"publisher","first-page":"16308","DOI":"10.1074\/jbc.M807725200","volume":"284","author":"JR Kim","year":"2009","unstructured":"Kim JR, Kee HJ, Kim JY, Joung H, Nam KI, Eom GH et al. Enhancer of polycomb1 acts on serum response factor to regulate skeletal muscle differentiation. J Biol Chem 2009; 284: 16308\u201316316.","journal-title":"J Biol Chem"},{"key":"BFleu2013316_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0092-8674(01)00450-0","volume":"106","author":"M Fuchs","year":"2001","unstructured":"Fuchs M, Gerber J, Drapkin R, Sif S, Ikura T, Ogryzko V et al. The p400 complex is an essential E1A transformation target. Cell 2001; 106: 297\u2013307.","journal-title":"Cell"},{"key":"BFleu2013316_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2010.09.010","volume":"143","author":"J Kim","year":"2010","unstructured":"Kim J, Woo AJ, Chu J, Snow JW, Fujiwara Y, Kim CG et al. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 2010; 143: 313\u2013324.","journal-title":"Cell"},{"key":"BFleu2013316_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cell.2012.08.026","volume":"151","author":"CY Lin","year":"2012","unstructured":"Lin CY, Loven J, Rahl PB, Paranal RM, Burge CB, Bradner JE et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 2012; 151: 56\u201367.","journal-title":"Cell"},{"key":"BFleu2013316_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cell.2012.08.033","volume":"151","author":"Z Nie","year":"2012","unstructured":"Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W et al. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 2012; 151: 68\u201379.","journal-title":"Cell"},{"key":"BFleu2013316_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1097-2765(00)80308-1","volume":"3","author":"R Sears","year":"1999","unstructured":"Sears R, Leone G, DeGregori J, Nevins JR . Ras enhances Myc protein stability. Mol Cell 1999; 3: 169\u2013179.","journal-title":"Mol Cell"},{"key":"BFleu2013316_CR31","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1038\/sj.onc.1206641","volume":"22","author":"X Yin","year":"2003","unstructured":"Yin X, Giap C, Lazo JS, Prochownik EV . Low molecular weight inhibitors of Myc-Max interaction and function. Oncogene 2003; 22: 6151\u20136159.","journal-title":"Oncogene"},{"key":"BFleu2013316_CR32","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.exphem.2006.06.019","volume":"34","author":"MJ Huang","year":"2006","unstructured":"Huang MJ, Cheng YC, Liu CR, Lin S, Liu HE . A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia. Exp Hematol 2006; 34: 1480\u20131489.","journal-title":"Exp Hematol"},{"key":"BFleu2013316_CR33","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/nsmb.2128","volume":"18","author":"JR Chittuluru","year":"2011","unstructured":"Chittuluru JR, Chaban Y, Monnet-Saksouk J, Carrozza MJ, Sapountzi V, Selleck W et al. Structure and nucleosome interaction of the yeast NuA4 and Piccolo-NuA4 histone acetyltransferase complexes. Nat Struct Mol Biol 2011; 18: 1196\u20131203.","journal-title":"Nat Struct Mol Biol"},{"key":"BFleu2013316_CR34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/genetics\/148.1.211","volume":"148","author":"DA Sinclair","year":"1998","unstructured":"Sinclair DA, Clegg NJ, Antonchuk J, Milne TA, Stankunas K, Ruse C et al. Enhancer of Polycomb is a suppressor of position-effect variegation in Drosophila melanogaster. Genetics 1998; 148: 211\u2013220.","journal-title":"Genetics"},{"key":"BFleu2013316_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1158\/0008-5472.CAN-05-2485","volume":"66","author":"F Micci","year":"2006","unstructured":"Micci F, Panagopoulos I, Bjerkehagen B, Heim S . Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1\/PHF1 and EPC1\/PHF1 in endometrial stromal sarcoma. Cancer Res 2006; 66: 107\u2013112.","journal-title":"Cancer Res"},{"key":"BFleu2013316_CR36","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/gcc.20681","volume":"48","author":"S Nakahata","year":"2009","unstructured":"Nakahata S, Saito Y, Hamasaki M, Hidaka T, Arai Y, Taki T et al. Alteration of enhancer of polycomb 1 at 10p11.2 is one of the genetic events leading to development of adult T-cell leukemia\/lymphoma. Genes Chromosomes Cancer 2009; 48: 768\u2013776.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu2013316_CR37","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.tcb.2006.07.007","volume":"16","author":"M Squatrito","year":"2006","unstructured":"Squatrito M, Gorrini C, Amati B . Tip60 in DNA damage response and growth control: many tricks in one HAT. Trends Cell Biol 2006; 16: 433\u2013442.","journal-title":"Trends Cell Biol"},{"key":"BFleu2013316_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0092-8674(00)81479-8","volume":"94","author":"SB McMahon","year":"1998","unstructured":"McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole MD . The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 1998; 94: 363\u2013374.","journal-title":"Cell"},{"key":"BFleu2013316_CR39","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1097-2765(00)80427-X","volume":"5","author":"MA Wood","year":"2000","unstructured":"Wood MA, McMahon SB, Cole MD . An ATPase\/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. Mol Cell 2000; 5: 321\u2013330.","journal-title":"Mol Cell"},{"key":"BFleu2013316_CR40","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1074\/jbc.M412509200","volume":"280","author":"C Attwooll","year":"2005","unstructured":"Attwooll C, Oddi S, Cartwright P, Prosperini E, Agger K, Steensgaard P et al. A novel repressive E2F6 complex containing the polycomb group protein, EPC1, that interacts with EZH2 in a proliferation-specific manner. J Biol Chem 2005; 280: 1199\u20131208.","journal-title":"J Biol Chem"},{"key":"BFleu2013316_CR41","doi-asserted-by":"crossref","unstructured":"Osaki H, Walf-Vorderwulbecke V, Mangolini M, Zhao L, Horton SJ, Morrone G et al. The AAA ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis. Leukemia 2013.","DOI":"10.1038\/leu.2013.42"},{"key":"BFleu2013316_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.gde.2009.11.001","volume":"20","author":"L Soucek","year":"2010","unstructured":"Soucek L, Evan GI . The ups and downs of Myc biology. Curr Opin Genet Dev 2010; 20: 91\u201395.","journal-title":"Curr Opin Genet Dev"},{"key":"BFleu2013316_CR43","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ccr.2008.10.018","volume":"14","author":"DJ Murphy","year":"2008","unstructured":"Murphy DJ, Junttila MR, Pouyet L, Karnezis A, Shchors K, Bui DA et al. Distinct thresholds govern Myc\u2019s biological output in vivo. Cancer Cell 2008; 14: 447\u2013457.","journal-title":"Cancer Cell"},{"key":"BFleu2013316_CR44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0092-8674(02)00738-9","volume":"109","author":"S Pelengaris","year":"2002","unstructured":"Pelengaris S, Khan M, Evan GI . Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 2002; 109: 321\u2013334.","journal-title":"Cell"},{"key":"BFleu2013316_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0092-8674(92)90123-T","volume":"69","author":"GI Evan","year":"1992","unstructured":"Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119\u2013128.","journal-title":"Cell"},{"key":"BFleu2013316_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/B978-0-12-386469-7.00004-9","volume":"110","author":"LR Thomas","year":"2011","unstructured":"Thomas LR, Tansey WP . Proteolytic control of the oncoprotein transcription factor Myc. Adv Cancer Res 2011; 110: 77\u2013106.","journal-title":"Adv Cancer Res"},{"key":"BFleu2013316_CR47","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.gene.2011.12.027","volume":"494","author":"B Luscher","year":"2012","unstructured":"Luscher B, Vervoorts J . Regulation of gene transcription by the oncoprotein MYC. Gene 2012; 494: 145\u2013160.","journal-title":"Gene"},{"key":"BFleu2013316_CR48","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/sj.leu.2404317","volume":"20","author":"S Malempati","year":"2006","unstructured":"Malempati S, Tibbitts D, Cunningham M, Akkari Y, Olson S, Fan G et al. Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias. Leukemia 2006; 20: 1572\u20131581.","journal-title":"Leukemia"},{"key":"BFleu2013316_CR49","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nature03845","volume":"436","author":"MT Hemann","year":"2005","unstructured":"Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C et al. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 2005; 436: 807\u2013811.","journal-title":"Nature"},{"key":"BFleu2013316_CR50","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.cell.2013.05.041","volume":"153","author":"B King","year":"2013","unstructured":"King B, Trimarchi T, Reavie L, Xu L, Mullenders J, Ntziachristos P et al. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability. Cell 2013; 153: 1552\u20131566.","journal-title":"Cell"},{"key":"BFleu2013316_CR51","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/sj.embor.embor821","volume":"4","author":"J Vervoorts","year":"2003","unstructured":"Vervoorts J, Luscher-Firzlaff JM, Rottmann S, Lilischkis R, Walsemann G, Dohmann K et al. Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep 2003; 4: 484\u2013490.","journal-title":"EMBO Rep"},{"key":"BFleu2013316_CR52","doi-asserted-by":"publisher","first-page":"10220","DOI":"10.1128\/MCB.25.23.10220-10234.2005","volume":"25","author":"F Faiola","year":"2005","unstructured":"Faiola F, Liu X, Lo S, Pan S, Zhang K, Lymar E et al. Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription. Mol Cell Biol 2005; 25: 10220\u201310234.","journal-title":"Mol Cell Biol"},{"key":"BFleu2013316_CR53","doi-asserted-by":"publisher","first-page":"10826","DOI":"10.1128\/MCB.24.24.10826-10834.2004","volume":"24","author":"JH Patel","year":"2004","unstructured":"Patel JH, Du Y, Ard PG, Phillips C, Carella B, Chen CJ et al. The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5\/PCAF and TIP60. Mol Cell Biol 2004; 24: 10826\u201310834.","journal-title":"Mol Cell Biol"},{"key":"BFleu2013316_CR54","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.1038\/cddis.2013.107","volume":"4","author":"JT Lynch","year":"2013","unstructured":"Lynch JT, Somerville TD, Spencer GJ, Huang X, Somervaille TC . TTC5 is required to prevent apoptosis of acute myeloid leukemia stem cells. Cell Death Dis 2013; 4: e573.","journal-title":"Cell Death Dis"},{"issue":"Database issue","key":"BFleu2013316_CR55","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkq929","volume":"39","author":"SA Forbes","year":"2011","unstructured":"Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 2011; 39 (Database issue): D945\u2013D950.","journal-title":"Nucleic Acids Res"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2013316.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2013316","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2013316.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:22:55Z","timestamp":1648740175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2013316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,29]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["BFleu2013316"],"URL":"https:\/\/doi.org\/10.1038\/leu.2013.316","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,29]]},"assertion":[{"value":"28 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}